A 0 1 0 1 O
prospective 2 13 2 13 O
patient 14 21 14 21 O
for 22 25 22 25 O
allogeneic 26 36 26 36 B-treatment
HCT 37 40 37 40 I-treatment
for 41 44 41 44 O
a 45 46 45 46 O
malignant 47 56 47 56 B-cancer
hematologic 57 68 57 68 I-cancer
disorder 69 77 69 77 I-cancer

Acute 0 5 78 83 B-cancer
Myeloid 6 13 84 91 I-cancer
Leukemia 14 22 92 100 I-cancer
( 23 24 101 102 I-cancer
AML 24 27 102 105 I-cancer
) 27 28 105 106 I-cancer
or 29 31 107 109 O
Acute 32 37 110 115 B-cancer
Lymphoblastic 38 51 116 129 I-cancer
Leukemia 52 60 130 138 I-cancer
( 61 62 139 140 I-cancer
ALL 62 65 140 143 I-cancer
) 65 66 143 144 I-cancer
in 67 69 145 147 O
first 70 75 148 153 O
or 76 78 154 156 O
second 79 85 157 163 O
remission 86 95 164 173 O

CML 0 3 174 177 B-cancer
in 4 6 178 180 O
accelerated 7 18 181 192 O
or 19 21 193 195 O
blast 22 27 196 201 O
phase 28 33 202 207 O
( 34 35 208 209 O
CML 35 38 209 212 O
- 38 39 212 213 O
AP 39 41 213 215 O
/ 41 42 215 216 O
BP 42 44 216 218 O
) 44 45 218 219 O
are 46 49 220 223 O
eligible 50 58 224 232 O
without 59 66 233 240 O
requirement 67 78 241 252 O
to 79 81 253 255 O
fail 82 86 256 260 O
tyrosine 87 95 261 269 B-treatment
kinase 96 102 270 276 I-treatment
inhibitor 103 112 277 286 I-treatment
therapy 113 120 287 294 I-treatment
, 120 121 294 295 O
but 122 125 296 299 O
must 126 130 300 304 O
be 131 133 305 307 O
in 134 136 308 310 O
remission 137 146 311 320 O
at 147 149 321 323 O
time 150 154 324 328 O
of 155 157 329 331 O
enrollment 158 168 332 342 O

Chronic 0 7 343 350 B-cancer
Myelomonocytic 8 22 351 365 I-cancer
Leukemia 23 31 366 374 I-cancer
( 32 33 375 376 I-cancer
CMML 33 37 376 380 I-cancer
) 37 38 380 381 I-cancer
with 39 43 382 386 O
< 44 45 387 388 O
10 46 48 389 391 B-upper_bound
% 48 49 391 392 I-upper_bound
blasts 50 56 393 399 O
in 57 59 400 402 O
the 60 63 403 406 O
bone 64 68 407 411 O
marrow 69 75 412 418 O

Current 0 7 419 426 O
or 8 10 427 429 O
prior 11 16 430 435 O
diagnosis 17 26 436 445 O
of 27 29 446 448 O
antecedent 30 40 449 459 O
Myelofibrosis 41 54 460 473 B-chronic_disease

Karnofsky 0 9 474 483 B-clinical_variable
> 10 11 484 485 O
70 11 13 485 487 B-lower_bound
% 13 14 487 488 I-lower_bound
( 15 16 489 490 O
an 16 18 490 492 O
attempt 19 26 493 500 O
to 27 29 501 503 O
quantify 30 38 504 512 O
cancer 39 45 513 519 B-cancer
patients 46 54 520 528 O
' 54 55 528 529 O
general 56 63 530 537 O
well 64 68 538 542 O
- 68 69 542 543 O
being 69 74 543 548 O
and 75 78 549 552 O
activities 79 89 553 563 O
of 90 92 564 566 O
daily 93 98 567 572 O
life 99 103 573 577 O
. 103 104 577 578 O
The 105 108 579 582 O
score 109 114 583 588 O
ranges 115 121 589 595 O
from 122 126 596 600 O
0 127 128 601 602 O
to 129 131 603 605 O
100 132 135 606 609 B-upper_bound
where 136 141 610 615 O
100 142 145 616 619 O
is 146 148 620 622 O
perfect 149 156 623 630 O
health 157 163 631 637 O
and 164 167 638 641 O
0 168 169 642 643 O
is 170 172 644 646 O
death 173 178 647 652 O
. 178 179 652 653 O
) 179 180 653 654 O

Males 0 5 655 660 B-gender

Patients 0 8 661 669 O
seropositive 9 21 670 682 O
or 22 24 683 685 O
PCR 25 28 686 689 O
positive 29 37 690 698 O
for 38 41 699 702 O
the 42 45 703 706 O
human 46 51 707 712 B-chronic_disease
immunodeficiency 52 68 713 729 I-chronic_disease
virus 69 74 730 735 I-chronic_disease
( 75 76 736 737 I-chronic_disease
HIV 76 79 737 740 I-chronic_disease
) 79 80 740 741 I-chronic_disease

Patients 0 8 742 750 O
with 9 13 751 755 O
evidence 14 22 756 764 O
of 23 25 765 767 O
Hepatitis 26 35 768 777 B-chronic_disease
B 36 37 778 779 I-chronic_disease
or 38 40 780 782 O
Hepatitis 41 50 783 792 B-chronic_disease
C 51 52 793 794 I-chronic_disease
PCR 53 56 795 798 B-treatment
positivity 57 67 799 809 O

Pregnant 0 8 810 818 B-pregnancy

Subjects 0 8 819 827 O
may 9 12 828 831 O
not 13 16 832 835 O
have 17 21 836 840 O
presence 22 30 841 849 O
of 31 33 850 852 O
active 34 40 853 859 O
CNS 41 44 860 863 B-chronic_disease
disease 45 52 864 871 I-chronic_disease
or 53 55 872 874 O
extramedullary 56 70 875 889 B-cancer
disease 71 78 890 897 I-cancer

Uncontrolled 0 12 898 910 B-chronic_disease
infections 13 23 911 921 I-chronic_disease

Use 0 3 922 925 O
of 4 6 926 928 O
T 7 8 929 930 B-treatment
cell 9 13 931 935 I-treatment
depletion 14 23 936 945 I-treatment
either 24 30 946 952 O
ex 31 33 953 955 O
vivo 34 38 956 960 O
or 39 41 961 963 O
in 42 44 964 966 O
vivo 45 49 967 971 O
( 50 51 972 973 O
i.e. 51 55 973 977 O
ATG 56 59 978 981 B-treatment
, 59 60 981 982 O
alemtuzumab 61 72 983 994 B-treatment
) 72 73 994 995 O
is 74 76 996 998 O
prohibited 77 87 999 1009 O

non 0 3 1010 1013 O
- 3 4 1013 1014 O
lactating 4 13 1014 1023 O
females 14 21 1024 1031 B-gender

non 0 3 1032 1035 B-pregnancy
- 3 4 1035 1036 I-pregnancy
pregnant 4 12 1036 1044 I-pregnancy

